[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100623934":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":31,"responsibleParty":110,"collaborators":11,"id":112,"slug":11,"hasResults":113,"nctId":114,"briefTitle":115,"officialTitle":116,"acronym":9,"eligibilityCriteria":117,"healthyVolunteers":113,"sex":118,"minAge":119,"maxAge":120,"enrollmentInfo":121,"targetDuration":11,"studyType":124,"phases":125,"briefSummary":127,"conditions":128,"keywords":11,"overallStatus":34,"whyStopped":11,"lastUpdateSubmitDate":132,"lastUpdatePostDateStruct":133,"startDateStruct":136,"completionDateStruct":138,"leadSponsor":140,"locationsCount":141},{"fullName":5,"class":6},"EUROS","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"NEMOST V2","EXPERIMENTAL",null,[13],"Device: NEMOST V2 growing domino",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"DEVICE","NEMOST V2 growing domino","The NEMOST spinal implant is a growth domino intended for the surgical treatment of progressive scoliosis in children.",[9],[21],{"name":22,"affiliation":23,"role":24},"Federico Solla, MD","Centre Hospitalier Universitaire de Nice","PRINCIPAL_INVESTIGATOR",[26],{"name":27,"role":28,"phone":29,"phoneExt":11,"email":30},"Célia Armanet, PHD","CONTACT","+330756848896","carmanet@euros.fr",[32,51,68,83,99],{"facility":33,"status":34,"city":35,"state":36,"zip":37,"country":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Hopital Lenval Nice","RECRUITING","Nice","Provence-Alpes-Côte d'Azur Region","06000","France",{"type":40,"coordinates":41},"Point",[42,43],7.26608,43.70313,{"lat":43,"lon":42},[46,50],{"name":47,"role":28,"phone":48,"phoneExt":11,"email":49},"Federico Solla","0492030491","federico.solla@hpu.lenval.com",{"name":47,"role":24,"phone":11,"phoneExt":11,"email":11},{"facility":52,"status":34,"city":53,"state":11,"zip":11,"country":38,"cosmosGeoPoint":54,"geoPoint":58,"contacts":59},"CHU Pellegrin","Bordeaux",{"type":40,"coordinates":55},[56,57],-0.58046,44.84124,{"lat":57,"lon":56},[60,64,65],{"name":61,"role":28,"phone":62,"phoneExt":11,"email":63},"Louis Boissière","0535544142","louis.boissiere@chu-bordeaux.fr",{"name":61,"role":24,"phone":11,"phoneExt":11,"email":11},{"name":66,"role":67,"phone":11,"phoneExt":11,"email":11},"Yan Lefèvre","SUB_INVESTIGATOR",{"facility":69,"status":70,"city":71,"state":11,"zip":11,"country":38,"cosmosGeoPoint":72,"geoPoint":76,"contacts":77},"Hospices Civils de Lyon","NOT_YET_RECRUITING","Lyon",{"type":40,"coordinates":73},[74,75],4.84789,45.74906,{"lat":75,"lon":74},[78,82],{"name":79,"role":28,"phone":80,"phoneExt":11,"email":81},"Vincent Cunin","04 27 85 57 95","vincent.cunin@chu-lyon.fr",{"name":79,"role":24,"phone":11,"phoneExt":11,"email":11},{"facility":84,"status":70,"city":85,"state":11,"zip":11,"country":38,"cosmosGeoPoint":86,"geoPoint":90,"contacts":91},"Hopital Armand Trousseau","Paris",{"type":40,"coordinates":87},[88,89],2.3488,48.85341,{"lat":89,"lon":88},[92,96,97],{"name":93,"role":28,"phone":94,"phoneExt":11,"email":95},"Raphael Vialle","0144736125","raphael.vialle@aphp.fr",{"name":93,"role":24,"phone":11,"phoneExt":11,"email":11},{"name":98,"role":67,"phone":11,"phoneExt":11,"email":11},"Mathilde Gaumé",{"facility":100,"status":70,"city":85,"state":11,"zip":11,"country":38,"cosmosGeoPoint":101,"geoPoint":103,"contacts":104},"Hopital Necker",{"type":40,"coordinates":102},[88,89],{"lat":89,"lon":88},[105,109],{"name":106,"role":28,"phone":107,"phoneExt":11,"email":108},"Lotfi Miladi","+33171196282","l.miladi@aphp.fr",{"name":106,"role":24,"phone":11,"phoneExt":11,"email":11},{"type":111,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100623934",false,"NCT07403084","Post-market Clinical Follow-up Study of NEMOST V2","Post-market Clinical Follow-up Study of NEMOST V2 Growing Domino","Inclusion Criteria:\n\n* Idiopathic, congenital, neuromuscular, or syndromic scoliosis : Progressive spinal deformity not managed by orthopedic treatment, and requiring primary surgical intervention.\n* The patient, as well as their parents or legal guardians, are informed of the participation in the study.\n* Patients aged from 5 to 17 yeas old, excepted the one who still have a potential for growth\n\nExclusion Criteria:\n\n* signs of local inflammation;\n* acute or chronic, local or systemic infections ;\n* non-reducible scoliosis ;\n* pathological obesity ;\n* allergy or intolerance to implanted materials;\n* insufficiency or absence of tissue coverage. The NEMOST implant should not be used in a spine that has already been instrumented or fused.","ALL","5 Years","17 Years",{"count":122,"type":123},140,"ESTIMATED","INTERVENTIONAL",[126],"NA","The NEMOST spinal implant is a growth domino intended for the surgical treatment of progressive scoliosis in children.\n\nAs part of post-market surveillance, EUROS is conducting a retrospective and prospective study to collect clinical and radiological data on the NEMOST growth domino.\n\nRetrospective and prospective multicenter post-market surveillance clinical study.\n\nThis study is interventional, non-randomized, and uncontrolled. The primary objective of this clinical study is to monitor complications related to the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children.\n\nThe secondary objective of this clinical study is to monitor the performance of the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children.\n\nThe study will include 140 patients.",[129,130,131],"Scoliosis Neuromuscular","Scoliosis Idiopathic","Consent Forms","2026-02-04",{"date":134,"type":135},"2026-02-11","ACTUAL",{"date":137,"type":135},"2025-12-19",{"date":139,"type":123},"2033-12-19",{"name":5,"class":6},5]